IceCure Medical (ICCM) Receivables (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Receivables data on file, last reported at $274000.0 in Q1 2026.

• Quarterly Receivables changed N/A year-over-year to $274000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $274000.0 (changed N/A YoY) and the FY2025 annual result came in at $331000.0, up 49.77% from the prior year.
• Receivables slipped to $274000.0 in Q1 2026 per ICCM's latest filing, from $331000.0 in the prior quarter.
• Across five years, Receivables topped out at $331000.0 in Q4 2025 and bottomed at $78000.0 in Q4 2022.
• The 5-year median for Receivables is $221000.0 (2024), against an average of $201400.0.
• The widest annual swing landed in 2022, when Receivables plunged 82.89%; it then jumped 114.56% in 2024.
• Tracing ICCM's Receivables over 5 years: stood at $78000.0 in 2022, then soared by 32.05% to $103000.0 in 2023, then jumped by 114.56% to $221000.0 in 2024, then jumped by 49.77% to $331000.0 in 2025, then fell by 17.22% to $274000.0 in 2026.
• Per Business Quant, the three latest ICCM Receivables figures stand at $274000.0 (Q1 2026), $331000.0 (Q4 2025), and $221000.0 (Q4 2024).

Peer Comparison